Zannis V I
Methods Enzymol. 1986;128:823-51. doi: 10.1016/0076-6879(86)28109-4.
This chapter provides the methodologies employed to study the polymorphism of human apoE. These and other related studies have advanced our understanding of the structure and function of this protein as follows: The complex array of human apoE observed by two-dimensional gel electrophoresis results from genetic variation and posttranslational modification. The genetic polymorphism of apoE is explained by the existence of three common alleles (epsilon 4, epsilon 3, epsilon 2) at a single structural gene locus. Combinations of above alleles can generate three homozygous (E4/4, E3/3, E2/2) and three heterozygous (E4/3, E3/2, E4/2) apoE phenotypes. The apoE phenotype E2/2 is found in 91% of patients with type III hyperlipoproteinemia and can be used as a molecular marker for the diagnosis of this disease. However, other rare or common apoE phenotypes have been observed in patients with type III HLP. ApoE originating from E2/2 phenotype (Arg 158 to Cys 158 substitution) has reduced affinity for the LDL receptor. This property of apoE2 can account partially for the accumulation of apoE-rich lipoprotein remnants in the plasma of patients with type III HLP. However, other genetic or environmental factors are necessary for the phenotypic expression of the disease.
本章介绍了用于研究人类载脂蛋白E多态性的方法。这些研究以及其他相关研究在以下方面增进了我们对该蛋白质结构和功能的理解:二维凝胶电泳观察到的人类载脂蛋白E的复杂阵列是由基因变异和翻译后修饰产生的。载脂蛋白E的基因多态性是由单个结构基因位点上存在的三个常见等位基因(ε4、ε3、ε2)所解释的。上述等位基因的组合可产生三种纯合子(E4/4、E3/3、E2/2)和三种杂合子(E4/3、E3/2、E4/2)载脂蛋白E表型。在91%的III型高脂蛋白血症患者中发现了载脂蛋白E表型E2/2,它可作为诊断该疾病的分子标志物。然而,在III型高脂蛋白血症患者中也观察到了其他罕见或常见的载脂蛋白E表型。源自E2/2表型(第158位精氨酸被半胱氨酸取代)的载脂蛋白E对低密度脂蛋白受体的亲和力降低。载脂蛋白E2的这一特性可以部分解释III型高脂蛋白血症患者血浆中富含载脂蛋白E的脂蛋白残粒的积累。然而,该疾病的表型表达还需要其他遗传或环境因素。